Blogger:Yulan Lin post doc at PRC A regular GP in Norway is responsible for examining, diagnosing and treating the patients on his/her list. The…
cancer
-
Blogger: Jose Teruel PhD candidate at MR Cancer group In a previous post in this blog I described how a new magnetic resonance imaging…
-
CancerResearch
How moustaches, mice and magnets contribute to prostate cancer research
by @NTNUhealth 25 November 2014Blogger: Debbie Hill, Post doctoral fellow at MR Cancer group As winter approaches us here in Trondheim, the art of keeping warm becomes more…
-
CancerResearch
To treat or not to treat? The role of PET/MRI in prostate cancer
by @NTNUhealth 11 November 2014Blog by: Mattijs Elschot Postdoctoral Fellow at MR Cancer Group Some prostate cancer patients need radical surgery to survive, whereas others can do without…
-
Blogger: Morteza Esmaeili Postdoctoral Fellow at MR Cancer Group, NTNU A new non-invasive method can identify a special mutation in a type of…
-
In laboratory tests at The Faculty of medicine, NTNU, Botox proved highly effective at suppressing gastric cancer in mice. The promising results have led…
-
Blogger: Jana Cebulla PhD Candidate at MR Cancer group Angiogenesis is the formation of new blood vessels from pre-existing vessels. This process takes…
-
Blogger: Ørnulf Paulsen Ørnulf Paulsen is a PhD student at European Palliative Care Research Centre, NTNU, and Senior Consultant in palliative medicine at Telemark…
-
CancerInflammatory and Immune SystemResearch
CEMIR Professor Harald Stenmark receives The King Olav V’s Cancer Research Award 2014
by @NTNUhealth 3 June 2014We congratulate Professor Stenmark with The esteemed award The King Olav V’s Cancer Research Award. Harald Stenmark is Professor at Radiumshospitalet, University of Oslo and…
-
BloodCancerChildren and youthInfectionResearch
Genetic profiling and side-effects of blood cancer treatment in children
by @NTNUhealth 11 February 2014Blogger: Bendik Lund During treatment of childhood blood cancer, great variations in side-effects are seen – both in terms of prevalence…